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Background: For patients in the intensive care unit (ICU) or under monitored anesthetic care (MAC), the precise 
monitoring of sedation depth facilitates the optimization of dosage and prevents adverse complications from under­ 
or over­sedation. For this purpose, conventional subjective sedation scales, such as the Observer's Assessment of 
Alertness/Sedation (OAA/S) or the Ramsay scale, have been widely utilized. Current procedures frequently disturb 
the patient's comfort and compromise the already well­established sedation. Therefore, reliable objective sedation 
scales that do not cause disturbances would be beneficial. We aimed to determine whether spectral entropy can be 
used as a sedation monitor as well as determine its ability to discriminate all levels of propofol­induced sedation 
during gradual increments of propofol dosage. 
Methods: In 25 healthy volunteers undergoing general anesthesia, the values of response entropy (RE) and state 
entropy (SE) corresponding to each OAA/S (5 to 1) were determined. The scores were then analyzed during each 0.5 
mcg/ml­ incremental increase of a propofol dose.
Results: We observed a reduction of both RE and SE values that correlated with the OAA/S (correlation coefficient 
of 0.819 in RE­OAA/S and 0.753 in SE­OAA/S). The RE and SE values corresponding to awake (OAA/S score 5), light 
sedation (OAA/S 3-4) and deep sedation (OAA/S 1-2) displayed differences (P < 0.05). 
Conclusions: The results indicate that spectral entropy can be utilized as a reliable objective monitor to determine 
the depth of propofol­induced sedation. (Korean J Anesthesiol 2012; 62: 234­239)
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Introduction
The precise monitoring of sedation depth facilitates the 
optimi  zation of dosage and prevents adverse complications 
from under­ or over­sedation. For this purpose, conventional 
subjective sedation scales, such as the OAA/S or the Ramsay 
scale, have been widely used for the management of patients in 
the intensive care unit (ICU), under monitored anesthetic care 
(MAC) or surgical patients in regional anesthesia. However, 
when these procedures are performed, they frequently disturb 
the patient’s comfort and compromise the already well­
established sedation. Thus, the ability to apply other reliable 
objective sedation scales that do not cause disturbances would 
be beneficial in the management of sedated patients. This 
concept raises concerns regarding the possibility of adopting 
EEG­based monitoring, a method applied to guarantee suffi­
cient intraoperative anesthesia depth, as an objective sedation 
scale to replace conventional subjective sedation scales. 
Previous investigations have analyzed the relationship 
between EEG­based monitors, such as the bispectral index (BIS) 
or spectral entropy (SE) and the conventional sedation scales in 
sedated patients. Despite a favorable correlation between the 
EEG­derived monitor and the conventional sedation scale, these 
studies did not indicate the monitor’s ability to discriminate all 
levels of sedation depth, as defined by the conventional sedation 
scales. Furthermore, over­sedation during therapy guided by the 
BIS monitor in addition to an insufficient correlation between 
the depth of sedation determined by the BIS value and hypnotic 
dosage were reported [1,2]. 
There are several reasons behind the insufficiency of the 
EEG­derived monitor to discriminate between all depths of 
sedation in order to guide sedation therapy [3­5]. First, the 
electromyographic (EMG) activity from eye movements can 
compromise the monitor’s ability, particularly in lightly sedated 
patients who are not paralyzed [4]. The entropy monitoring 
consists of SE, devoid of EMG interference, and may thus 
be beneficial in this situation. Second, when the combined 
use of opioids and hypnotics is applied, the overall depth of 
sedation is synergistic via the extra­cortical pathway. However, 
the EEG­derived monitor (which reflects cortical activity in 
the determination of sedation depth) cannot detect extra­
cortically potentiated sedation; indeed, even the BIS value that 
defines sufficient anesthesia depth may shift to higher values 
in the combined use of opioids and hypnotics [2,3,5,6]. This 
discrepancy would be exaggerated during opioid­accentuated 
sedation therapy in the ICU. 
For establishing the efficacy of the EEG­derived monitor 
(for both the titration of hypnotic doses and guiding the depth 
of hypnotic­based sedation), the current study analyzed the 
changes of entropy corresponding to the OAA/S value during a 
progressive deepening of propofol­induced sedation except for 
the opioids due to the undetectable sedative effect.
Materials and Methods
The study was approved by the Institutional Review Board 
and written informed consent from the 25 patients (20-54 
years of age), undergoing elective orthopedic surgery with 
general anesthesia, were enrolled in this prospective study. 
Exclusion criteria were a history of cardiac, pulmonary, liver or 
renal disease, or significant obesity. Long term user of central 
nervous system activator drugs, including benzodiazepines or 
opiates was excluded. An intravenous line was placed in the 
patient’s forearm and glycopyrrolate (0.2 mg) was administered 
intravenously in the patient holding area. Upon the patient’s 
arrival to the operating room, routine monitoring including 
an electrocardiogram, pulse oximetry and non­invasive blood 
pressure were initiated. To monitor spectral entropy, a three­
element electrode (Entropy sensor
TM Datex­Ohmeda, Finland) 
with a plug­in monitor (M­Entropy plug­in module, Datex­
Ohmeda, Finland) was applied, as outlined in the manu­
facturer’s manual. 
Patients were instructed to close and open their eyes when 
the investigator called their name and shook their body to deter­
mine the OAA/S score (from 5 to 1) during the study period 
(Table 1). After the patient became comfortable in the operating 
room, baseline values for the RE (100 to 0), SE (91 to 0) were 
recorded and compared to the RE and SE values corresponding 
to the OAA/S score of 5. 
Propofol was administered using a computer­assisted, target­
controlled infusion (TCI) device (Orchestra
TM and Base A
TM, 
Fresenius Vial Infusion Systems, France) with a maximum flow 
rate of 1,200 ml/h, according to the pharmacokinetic­dynamic 
model published by Schnider and coworkers [7,8]. Initially, the 
target effect­site concentration of propofol was set to 1.0 μg/
ml and increased incrementally by 0.5 μg/ml to deepen the 
sedation depth. At each increment, the RE and SE values were 
recorded and an equilibrium of propofol plasma and effect­site 
concentrations were displayed on the TCI device. OAA/S scores 
were then immediately determined. The following sequence 
was maintained throughout the study protocol: (1) RE and SE 
Table 1. Observer’s Assessment of Alertness/Sedation Scale
Score Responsiveness
5
4
3
2
1
Awake and responds to name, spoken in normal tone
Lethargic response to name, spoken in normal tone
Responds only after name called loudly and/or repeatedly
Responds only after name called loudly and after mild 
  shaking of body
No response after name is called loudly with mild shaking236 www.ekja.org
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scores, (2) the OAA/S score and (3) the RE and SE values were 
defined as those corresponding to each OAA/S score. 
During propofol administration a face mask was fitted 
to measure the ETCO2. Observing the slugged respiration, 
assisted or controlled ventilation of O2 (6 L/min) was applied 
to maintain the ETCO2 within 35-40 mmHg. After achieving the 
OAA/S 1, the study was completed and rocuronium (0.6-0.9 
mg/kg) was administered to facilitate tracheal intubation. 
The correlations between the RE and SE values and the 
OAA/S score were determined using linear regression and 
Spearman’s correlation. To evaluate the ability of entropy to 
discri  minate between the status of awake, light sedation and 
deep sedation, RE and SE corresponding to the OAA/S scores of 
5, 3-4, and 1-2 were analyzed by using the Kruskal­Wallis one 
way analysis of variance, and pair­wise comparisons among 
the OAA/S groups were performed using a Dunn’s test. The 
analyses were performed using the statistical program (Sigma 
Stat
TM ver. 3.1, Systat Software, USA). 
Results
One patient was excluded from the study due to a repetition 
of abrupt fluctuations in the RE and SE values on calling the 
patient’s name and an intermittent agitated response. Another 
patient was excluded due to unexpected heavy sedation at 
lower doses of propofol resulting in failure to determine the 
status of the OAA/S score of 4-3. 
Data from twenty­five patients (12 male / 13 female) of ages 
(41 ± 10 years), height (167 ± 8 cm) and weight (65 ± 7 kg) were 
included for this analysis. The median values of the RE and SE 
values corresponding to OAA/S scores of 5, 4, 3, 2 and 1 are 
shown in Table 2. The changes of RE and SE values showed 
significant correlation and predictability with changes in the 
OAA/S score (n = 75, correlation coefficients of 0.811 and 0.802, 
respectively, and r = 0.811, r
2 = 0.657, y = 17.987 + 15.653 x; and 
r = 0.802, r
2 = 0.644, y = 16.1 + 14.4 x, respectively)(Fig. 1). The 
median (25-75%) of the RE and SE values corresponding to 
awake, light sedation and deep sedation were significantly 
different (96 [94-98], 76 [55-93] and 40 [30-45], respectively; 
P < 0.001) and (86 [85-89], 69 [50-81] and 36 [29-39], 
respectively; P < 0.001), and their pair­wise comparisons showed 
significantly different values (P < 0.001)(Fig. 2).
Discussion
The OAA/S score was selected for this study as it has been 
well regarded as demonstrating correlation with hypnotic­
based sedation, even in the ICU setting, in previous prospective 
studies [9]. Moreover, its efficacy was equal to the Ramsay scale 
as determined by comparison with other EEG­based monitors, 
Fig. 1. Response entropy (A) and state entropy (B) values corresponding to each of the observer’s assessment of alertness/sedation (oaa/s) 
score. The values of both RE and SE displayed a significant correlation with the OAA/S scores (r = 0.811, r
2 = 0.657, y = 17.987 + 15.653 x) and (r = 
0.802, r
2 = 0.644, y = 16.1 + 14.4 x), respectively.
Table 2. Response Entropy (RE) and State Entropy (SE) Values for Each OAA/S Score
OAA/S 5            OAA/S 4  OAA/S 3   OAA/S 2    OAA/S 1
RE          
SE          
95.7 (91-99)
86.5 (82-90)
84.7 (46-99) 
73.7 (40-87) 
63.4 (30-99) 
57.5 (32-88) 
42.3 (25-95)
39.1 (24-89)  
38.7 (15-69)
33.8 (14-60)
Data shown are median values (range; minimum-maximum). The median values corresponding to the OAA/S scores in both RE and SE groups 
displayed a significant difference (P < 0.001). OAA/S: Score of Observer’s Assessment of Alertness/Sedation.237 www.ekja.org
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although it has several limitations and variations regarding its 
clinical application [9­14]. 
The role of the EEG­derived monitor in the operating room 
is focused on ensuring a sufficient sedation depth and avoiding 
intraoperative recall. However, the EEG­derived monitor should 
focus on the ability to discriminate between all depths of sedation 
and to guide the correct hypnotic doses. Further  more, as the 
depth of sedation is generally much lighter than for general 
anesthesia in slightly sedated patients, a reliable objective 
sedation entropy monitor should be able to distinguish sedation 
depth, rather than to guarantee a sufficient depth of sedation. 
A clearly defined sedation depth facilitates the precise dose 
of hypnotic thereby avoiding over­ or under­sedation. We have 
demonstrated that EEG entropy responds to the progressive 
deepening of propofol­sedation, and the relationship between 
the sedation depths is defined by both the entropy and the 
OAA/S scores. The gradual reduction of RE and SE values 
during the progressive deepening of sedation depth was 
observed to correlate with the changes in the OAA/S score in 
agree  ment with previous investigations [5,15­17]. We observed 
a significant discrimination between light and deep sedation, 
which is meaningful for clinical applications compared with a 
previous study [17].
The original entropy scale (that continually varies between 
0 and 1) was transformed to a scale of full integers between 0 
and 100. A relatively large portion of the original mathematical 
scale of entropy values range from levels of hypnosis that can 
be considered too deep, whilst the most interesting range of 
adequate hypnosis and emergence lies between 0.5 and 1.0. 
For this reason, the transformation of the original continuous 
entropy scale is converted via a non­linear transformation (e.g., 
the original entropy of 0.5/1.0 is transformed to a presented 
entropy scale of 30/100) [18]. Spectral entropy consists of both 
RE and SE as an immediate response to a given stimulus; RE 
rises first followed by an increase in SE. Vakkuri and colleagues 
demonstrated that RE indicates the emergence from anesthesia 
11 seconds earlier than SE, and 12.4 seconds earlier than BIS; 
however, these were recorded evaluating both the loss and 
regaining of consciousness [19]. 
As SE in spectral entropy is devoid of EMG interference, 
it may prove more reliable than other EMG­sensitive, EEG­
derived monitors. Considering that most of the recent ICU 
sedation regimens do not include the use of neuromuscular 
blocking agents, SE may be additionally important as a reliable 
sedation monitor in the ICU. 
When EEG­derived monitors are applied during opioid­
sedative combined regimens, such as propofol­remifentanil 
or midazolam­fentanyl, their inability to detect the opioid 
extra­cortical sedative effect, in addition to the high reference 
values in the same depth of sedation, should be considered [6]. 
Vanluchene and co­workers [3] observed that the sensitivity 
and specificity for detection of loss of responsiveness to verbal 
commands were decreased with increasing effect site target 
concentrations of remifentanil. Hernández­Gancedo et al. 
[4] additionally demonstrated that an overlap of entropy 
values corresponded to a Ramsay score of 4-6. Furthermore, 
recent analgesia­based sedation regimens in the ICU, rather 
than sedative­based sedation regimens, may require more 
sophisticated objective measures capable of measuring all 
sedation depths produced by the opioid synergistic effect of 
reinforcing sedation. Our investigation also demonstrates that 
the RE and SE values of a deeply sedated status were confined 
to an OAA/S of 1-2; additionally, they overlapped and were 
not distinguishable due to the non­linear transformation of 
entropy. However, RE and SE values confined to light sedation 
(OAA/S 3-4) were significantly different from those confined 
to an awake (OAA/S 5) or deep sedation (OAA/S 1-2) (Fig. 2). 
Considering that the usual target depth of sedation during 
Fig. 2. Response entropy (A) and state entropy (B) during various sedation levels. Each sedation group differed from the others by all pair-wise 
multiple comparison procedures (Dunn's method [P < 0.005]).238 www.ekja.org
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the management of patients is light, these data indicate that 
entropy monitoring can be used, enabling the administration of 
hypnotic doses required to maintain adequate sedation as well 
as avoiding adverse outcomes from incorrect sedation levels.
Schmidt et al. [5] speculated about the limited ability of 
entropy measurements to distinguish between the two states of 
sedation (the loss of a verbal response corresponded to OAA/S 
score < 1 and an awake state corresponded to OAA/S scores of 
2-5). However, their criteria of awake did not concur with those 
used in the current study (OAA/S score 5). Here, the SE values 
confined to OAA/S scores of 5 and 4 were significantly different, 
whilst the RE values were indistinguishable. This indicates that 
SE monitoring is beneficial, probably due to the avoidance of 
EMG interference, particularly during the lightly sedated status. 
This also suggests the possible efficacy of entropy monitoring in 
titration sedation­depth during propofol­sedation for patients 
in the ICU or surgical patients with regional anesthesia who are 
not taking neuromuscular blockers.
The possible limitation of our study was not to evaluate its 
reliability in critically ill patients, in patients who asked for 
sedatives undergoing lower limb surgery or requiring MAC. 
Other confounding factors may influence entropy scores 
including sleep, temperature, age and drugs such as opioids, 
muscle relaxants, and ketamine. As the aim of the present study 
was to determine the entropy values specific to each depth 
of sedation through the OAA/S scores, the interval for each 
propofol concentration was not determined. Furthermore, 
the effect­site concentration of propofol in TCI should not 
guide the sedation depth alone. We observed the clinically 
sedative responsiveness to propofol independent of the effect­
site concentration. Even at identical propofol­concentrations, 
patients displayed differences in the levels of sedation depth 
in the conventional OAA/S scale and entropy monitoring. In 
the current study, the depth of propofol sedation determined 
by both OAA/S and entropy monitoring were heavily affected 
by external stimuli, such as the inconvenience of determining 
OAA/S, rather than the propofol effect­site concentration. 
In conclusion, the reduction in spectral entropy values 
correlated well with the reduction in the OAA/S scores during 
the deepening of propofol­sedation. Entropy monitoring could 
thus distinguish the lightly sedated status from the awake and 
deeply sedated status defined by the OAA/S scores. These 
results indicate that entropy monitoring can be utilized as a 
reliable objective monitor enabling the titration of a hypnotic 
dosage for the maintenance of adequate sedation as well as for 
avoiding adverse outcomes from under­ or over­sedation.
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